The trajectory of companies tied to Viagra's history presents a complex investment scenario . While the initial surge generated substantial profits , generic competition have significantly diminished market share . Investing in connected pharmaceutical businesses now requires a thorough assessment of patent protection , evolving healthcare shifts ,